Fisher & Paykel Healthcare Corporation Ltd (FPH) - Total Liabilities
Based on the latest financial reports, Fisher & Paykel Healthcare Corporation Ltd (FPH) has total liabilities worth AU$639.89 Million AUD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Fisher & Paykel Healthcare Corporation Ltd - Total Liabilities Trend (2000–2025)
This chart illustrates how Fisher & Paykel Healthcare Corporation Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Fisher & Paykel Healthcare Corporation Ltd Competitors by Total Liabilities
The table below lists competitors of Fisher & Paykel Healthcare Corporation Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Penumbra Inc
NYSE:PEN
|
USA | $385.67 Million |
|
Neurocrine Biosciences Inc
NASDAQ:NBIX
|
USA | $1.38 Billion |
|
Impala Platinum Holdings Ltd
JSE:IMP
|
South Africa | ZAC39.24 Billion |
|
Sterling Construction Company Inc
NASDAQ:STRL
|
USA | $1.53 Billion |
|
Gaming & Leisure Properties
NASDAQ:GLPI
|
USA | $7.83 Billion |
|
LIG Nex1 Co Ltd
KO:079550
|
Korea | ₩5.90 Trillion |
|
Samsung Fire & Marine Insurance
KO:000810
|
Korea | ₩71.79 Trillion |
|
HDFC Asset Management Company Limited
NSE:HDFCAMC
|
India | Rs6.92 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Fisher & Paykel Healthcare Corporation Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fisher & Paykel Healthcare Corporation Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fisher & Paykel Healthcare Corporation Ltd (2000–2025)
The table below shows the annual total liabilities of Fisher & Paykel Healthcare Corporation Ltd from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | AU$660.40 Million | +26.37% |
| 2024-03-31 | AU$522.60 Million | +23.77% |
| 2023-03-31 | AU$422.22 Million | +6.68% |
| 2022-03-31 | AU$395.79 Million | -22.32% |
| 2021-03-31 | AU$509.50 Million | +14.05% |
| 2020-03-31 | AU$446.73 Million | +58.54% |
| 2019-03-31 | AU$281.79 Million | +13.62% |
| 2018-03-31 | AU$248.00 Million | +24.97% |
| 2017-03-31 | AU$198.45 Million | -2.34% |
| 2016-03-31 | AU$203.20 Million | +2.30% |
| 2015-03-31 | AU$198.63 Million | -11.41% |
| 2014-03-31 | AU$224.20 Million | -9.00% |
| 2013-03-31 | AU$246.37 Million | +10.03% |
| 2012-03-31 | AU$223.90 Million | +9.59% |
| 2011-03-31 | AU$204.32 Million | +12.33% |
| 2010-03-31 | AU$181.90 Million | -13.15% |
| 2009-03-31 | AU$209.44 Million | +53.99% |
| 2008-03-31 | AU$136.00 Million | +67.59% |
| 2007-03-31 | AU$81.15 Million | +27.85% |
| 2006-03-31 | AU$63.48 Million | +65.83% |
| 2005-03-31 | AU$38.28 Million | +16.18% |
| 2004-03-31 | AU$32.95 Million | -8.31% |
| 2003-03-31 | AU$35.94 Million | -17.30% |
| 2002-03-31 | AU$43.45 Million | -48.64% |
| 2001-03-31 | AU$84.59 Million | -68.41% |
| 2000-03-31 | AU$267.80 Million | -- |
About Fisher & Paykel Healthcare Corporation Ltd
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The com… Read more